FDA Approves Hemophilia B Second Gene Therapy.

Published Date: 29 Apr 2024

Standard prophylactic factor IX was found to be noninferior to one dose of fidanacogene elaparvovec.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A new therapeutic approach could help tackle radiation resistance in childhood brain tumors

2.

Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer

3.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

4.

After HSCT, a longer course of letermovir prophylaxis decreased the risk of cytomegalovirus infection.

5.

Cabozantinib Improves PFS for Advanced Neuroendocrine Tumors


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot